SI-BONE Names Jeryl (“Jeri”) Hilleman to Board of Directors Dec 4, 2019 04:05PM
SI-BONE Names Jeryl (“Jeri”) Hilleman to Board of Directors Dec 4, 2019 04:05PM
Divide & Conquer, Developing New Class of Cancer Therapeutics to Disrupt Cell-to-Cell Communication, Emerges from Stealth as New Paper by Co-Founder is Published in Nature Sep 18, 2019 01:00PM
Novocure Announces Addition to Its Board of Directors Aug 2, 2018 07:30AM
Palladio Biosciences Formed to Develop Transformative Medicines for Orphan Diseases of the Kidney May 23, 2017 12:03PM


Mar 29, 2016 04:00AM Gadeta Closes EUR 7 Million Series A Financing to Advance Novel Cancer Immunotherapies to the Clinic
Mar 8, 2016 04:00AM Capella Bioscience Completes Series A Financing of £11 million ($15.5 million) to Progress Antibody Pipeline
Jul 3, 2014 10:00AM Minerva Neurosciences, Inc. (NASDAQ: NERV) to Ring The NASDAQ Stock Market Closing Bell